2598 results about "Benzyl group" patented technology

The invention relates to the technical field of dielectric material preparation, in particular to a preparation method of a polymer dielectric film. The preparation method comprises the following steps: in an inert atmosphere, mixing a diamine monomer, a dianhydride monomer and an organic solvent, and carrying out condensation polymerization to obtain a precursor solution; wherein one of the diamine monomer and the dianhydride monomer contains benzyl groups; and carrying out imidization reaction and benzyl free radical cross-linking reaction on the precursor solution to obtain the polymer dielectric film. The glass transition temperature (Tg) of the polymer dielectric film prepared by the preparation method is improved, the modified film has excellent breakdown electric field and energy storage density in a high-temperature environment of 250 DEG C, and other complicated and high-technical-content processes are not added on the basis of a process for synthesizing a commercial polymer dielectric film; vacuum environment crosslinking is not needed, environmental protection and energy saving are achieved, the reaction degree is controllable, the surface of the prepared polymer dielectric film is smooth, and the cross section has no obvious defects.

The invention discloses a synthesis method of vitamin C ethyl ether, and belongs to the technical field of vitamin derivative synthesis. The synthesis method comprises the following steps: adding vitamin C, benzaldehyde and a catalyst into a first organic solvent, carrying out an aldolization reaction, adding an organic alkali after the aldolization reaction is finished, carrying out a neutralization reaction, adding an alkylation reagent, carrying out an alkylation reaction, and removing the first organic solvent after the alkylation reaction is finished, so as to obtain the vitamin C benzaldehyde. The preparation method comprises the following steps: adding a first organic solvent into a first organic solvent, pulping, filtering, collecting filter residues, washing and drying to obtain 5, 6-O-benzyl-3-O-ethyl-L-ascorbic acid, carrying out hydrogenation deprotection on the 5, 6-O-benzyl-3-O-ethyl-L-ascorbic acid, filtering after hydrogenation deprotection, collecting filtrate, crystallizing, collecting precipitate, washing and drying to obtain the 5, 6-O-benzyl-3-O-ethyl-L-ascorbic acid. The vitamin C ethyl ether is obtained. The synthesis method provided by the invention is simple to operate and high in production efficiency, and the obtained vitamin C ethyl ether is high in yield and purity.

The invention relates to the technical field of environmental materials and water treatment, in particular to a graphene amino silica gel composite adsorbent for heavy metal wastewater treatment and a preparation method thereof.The graphene amino silica gel composite adsorbent is prepared from # imgabs0 nanoparticles, an amino-functionalized silicon dioxide coating layer, carboxylated reduced graphene oxide, a polydopamine modification layer and tetraethyl orthosilicate; the coating is prepared from the following raw materials: 3-aminopropyltriethoxysilane, 3-mercaptopropyltrimethoxysilane, N-((4-vinyl benzyl) amino) diacetic acid, chitosan, beta-cyclodextrin, hexadecyl trimethyl ammonium bromide, polyethylene glycol, L-ascorbic acid, 1-ethyl-3-(3-dimethyl aminopropyl) carbodiimide hydrochloride and N-hydroxysuccinimide. The composite adsorbent shows excellent adsorption performance on various heavy metal ions, and the adsorption performance is far higher than that of traditional adsorption materials and existing composite adsorbents.

The present invention relates to crystal modifications of 1,1-dioxo-3,3-dibutyl-5-phenyl-7-methylthio-8-(N-{(R)-α-[N-((S)-1-carboxypropyl)carbamoyl]-4-hydroxybenzyl}carbamoylmethoxy)-2,3,4,5-tetrahydro-1,2,5-benzothiadiazepine (odevixibat), more specifically crystal modifications 1 and 2 of odevixibat. The invention also relates to a process for the preparation of crystal modification 1 of odevixibat, to a pharmaceutical composition comprising crystal modification 1, and to the use of this crystal modification in the treatment of various conditions as described herein.

One embodiment of the present invention relates to a compound comprising an indene ring, a vinylbenzyl group, and an aromatic ring-containing group having 6 or more carbon atoms and not having a polymerizable carbon-carbon double bond, the vinylbenzyl group and the aromatic ring-containing group being each directly bonded to the indene ring.

The invention belongs to the field of skin care products, and particularly relates to an anti-wrinkle and anti-aging composition as well as a preparation method and application thereof, and the anti-wrinkle and anti-aging composition comprises neurotransmitter inhibition peptide, signal peptide, madecassoside, inositol and glycosylglycerol. The neurotransmitter inhibition type peptide is at least three of acetyl hexapeptide-8, arginine / lysine polypeptide, dipeptide diaminobutyrylbenzylamide diacetate and acetyl octapeptide-3, and the signal type peptide is at least two of palmitoyl pentapeptide-4, decapeptide-4 and acetyl tetrapeptide-9. Compared with the prior art, all the components of the anti-wrinkle and anti-aging composition act on different anti-aging pathways and can be matched with one another from multiple aspects of oxidation resistance, inflammation resistance, moisturizing, cell viability enhancement, wrinkle reduction and the like, a more comprehensive and better anti-aging effect is provided, skin aging is comprehensively resisted, the skin is in a more young state, and the anti-wrinkle and anti-aging composition has the advantages that the anti-wrinkle and anti-aging effects are achieved. And the anti-wrinkle and anti-aging composition is small in irritation and good in stability.

The present invention provides a divinylbenzylfluorene and a preparation method and application thereof, a divinylbenzylfluorene hydrocarbon resin and a preparation method and application thereof, and relates to the technical field of high-frequency substrate materials. The divinylbenzylfluorene hydrocarbon resin prepared by using one or a mixture of any proportion of 9,9-bis(2-vinylbenzyl)-9H-fluorene and 9,9-bis(4-vinylbenzyl)-9H-fluorene provided by the present invention as raw materials has very low dielectric constant and dielectric loss tangent, and the higher the content of 9,9-bis(2-vinylbenzyl)-9H-fluorene, the smaller the dielectric loss tangent of the divinylbenzylfluorene hydrocarbon resin; moreover, the solubility of 9,9-bis(2-vinylbenzyl)-9H-fluorene and 9,9-bis(4-vinylbenzyl)-9H-fluorene provided by the present invention in toluene and 2-butanone is high, and has good application prospects as a cross-linking agent of the main resin or olefin resin component of a high-frequency substrate.

The invention provides a synthesis method of 6-(t-butyloxycarboryl)-3, 6-diazabicyclo [3.1. 1] heptane, which comprises the following steps: starting from N-benzyl-2, 6-piperidinedione, firstly forming a dibromide 1, then forming a bridge ring intermediate 2 under alkaline conditions, then removing benzyl to obtain an intermediate 3, then reducing dicarbonyl to form free amine 4, and finally synthesizing the 6-(t-butyloxycarboryl)-3, 6-diazabicyclo [3.1. 1] heptane. Then performing Boc protection on amino to obtain an intermediate 5, and performing debenzylation to form a target product. According to the synthesis method, few impurities are generated, and the product is easy to purify and high in purity, so that the total yield is increased, the unit cost is effectively reduced, and large-scale industrial production is facilitated.

The invention discloses a method for simultaneously detecting residual quantity of 19 plant growth regulators in traditional Chinese medicinal materials, and belongs to the technical field of traditional Chinese medicinal material detection. The 19 plant growth regulators in the detected traditional Chinese medicinal materials are gibberellins, 4-chlorophenoxyacetic acid, 6-benzyladenine, paclobutrazol, 3-indolebutyric acid, thidiazuron, 2, 4-dihydroxyacetophenone and 2, 4-dihydroxyacetophenone respectively. The pesticide is prepared from the following raw materials: sodium 4-dichlorphenoxyacetate, forchlorfenuron, 3-indoleacetic acid, 4-fluorophenoxyacetic acid, isopentenyl adenine, imazalil, N-N '-diphenylurea, mepiquat chloride, diethyl aminoethyl hexanoate, 1-naphthylacetic acid amine, brassin, abscisic acid and 3-indolepropionic acid. According to the method, the QUECHERS traditional Chinese medicinal material sample on-machine pretreatment technology is applied, the ultra-high performance liquid chromatography-tandem mass spectrometry is established to measure the residual quantity of the 19 plant growth regulators in the medicinal materials, and the detection method is simple, clear, few in operation steps, extremely easy to operate, good in linear relation, good in sensitivity and high in accuracy.

The invention discloses a high-barrier antibacterial packaging material, a preparation method thereof and a packaging bag, and belongs to the technical field of packaging, the packaging material comprises the following raw materials by weight: 75-85 parts of polylactic acid, 15-25 parts of poly (butylene succinate), 2-6 parts of epoxidized urushiol, and 1-3 parts of benzyl quaternary ammonium salt modified montmorillonite; the epoxidized urushiol is prepared by carrying out epoxidation reaction on urushiol and organic peroxy acid; the packaging material further comprises the following raw materials: 2-5 parts of sepiolite fiber loaded magnesium oxide; according to the invention, biodegradable polylactic acid and poly (butylene succinate) are taken as base materials, and epoxidized urushiol is taken as a reactive compatilizer, so that the compatibility between polylactic acid and poly (butylene succinate) is improved, and meanwhile, the binding property between a polymer matrix and benzyl quaternary ammonium salt modified montmorillonite and sepiolite loaded magnesium oxide is enhanced; the packaging material with good mechanical property, barrier property and antibacterial property is obtained.

The invention belongs to the technical field of preparation of blocking removers, and particularly relates to a composite chelating blocking remover for an oil field and a preparation method of the composite chelating blocking remover. The composite chelating blocking remover for the oil field is prepared from the following raw materials in percentage by mass: 7 to 9 percent of 1-butyl-3-methylimidazole dodecyl sulfonate, 5 to 7 percent of erucamide propyl hydroxypropyl sulfobetaine, 3 to 4 percent of di-(2-ethylhexyl) sodium sulfosuccinate, 4 to 5 percent of ethylenediamine di-o-hydroxyphenylacetic acid, 5 to 7 percent of N, N '-di (2-hydroxybenzyl) ethylenediamine-N, N'-bis (2-hydroxybenzyl)-N, N '-bis (2-ethylhexyl)-N, N'-bis (2-hydroxybenzyl)-N, N '-bis (2-hydroxybenzyl)-N, N'-bis (2-hydroxyphenyl)-N, N '-bis (2-hydroxyphenyl)-N, N'-bis (2-hydroxyphenyl)-N The cleaning agent is prepared from the following components in percentage by weight: 3 to 4 percent of N, N '-diacetic acid, 2 to 3 percent of O-(3-(benzyloxy) propyl) hydroxylamine, 1 to 2 percent of heptadecenyl hydroxyethyl imidazoline quaternary ammonium salt, 1 to 1.5 percent of dimethyl diallyl ammonium chloride homopolymer and the balance of water. The composite chelating blocking remover for the oil field has excellent scale dissolution rate and paraffin inhibition rate when being applied to complex scale blocking removal of the oil field.

The invention relates to a perovskite solar cell, which comprises a substrate, a hole transport layer, a perovskite film layer, an electron transport layer and an electrode layer, the perovskite film layer comprises a perovskite material ABX3 and an additive, the additive contains an electron withdrawing group, the additive and the perovskite material are mixed to form the perovskite film layer, and the hole transport layer is arranged between the hole transport layer and the perovskite film layer. A modification material layer is arranged between the perovskite film layer and the electron transport layer, and the modification material layer forms n-type doping on a contact interface of the perovskite film layer. According to the cell, diethyl (3-(trifluoromethyl) benzyl) phosphonate is doped in a perovskite film layer, so that intrinsic weak n-type perovskite is converted into a p-type perovskite at a position close to a hole transport layer, and a surface modification material is arranged between the perovskite film layer and an electron transport layer, so that the perovskite film layer close to the electron transport layer is converted into an n-type perovskite film layer, an efficient p-n junction is formed, and the photoelectric conversion efficiency of the cell is improved. And the efficiency of the perovskite cell is improved.

The present invention relates to the technical field of coatings and discloses a method for preparing an EVA waterproof coating. Activated montmorillonite reacts with toluene diisocyanate to obtain isocyanate-modified montmorillonite. EVA is hydrolyzed under the catalysis of potassium hydroxide to obtain hydroxylated EVA. An epoxy trisiloxane intermediate reacts with terephthalic acid under ring-opening esterification with benzyltriethylammonium chloride to obtain p-hydroxytrisiloxane benzoate. P-hydroxytrisiloxane benzoate, hydroxylated EVA, and isocyanate-modified montmorillonite are cross-linked with toluene diisocyanate under the catalysis of stannous octoate, and a defoamer and a dispersant are added thereto and stirred uniformly to obtain an EVA waterproof coating. The EVA waterproof coating prepared by the present invention has good mechanical properties and waterproof properties.

The present invention refers to an antagonist of imidazoline-1 receptor (I1R) for use in the prevention and / or treatment of an autoinflammatory or autoimmune disease in a human subject, selected from the group consisting of (±)-2-endo-amino-3-exo- isopropylbicyclo[2.2.1]heptane (synonym: AGN192403), N-benzylguanidine, 2-(2- Fluoro-5-methylphenyl)-4,5-dihydro-1H-imidazole (synonym: S23757), 2-(2-chloro-4-iodo-phenylamino)-5-methyl-pyrroline (synonym: LNP911), 1-(4, 5-dihydro-1H-imidazol- 2-yl)isoquinoline (synonym: BU98008), 5-[2-bromophenoxy)methyl]-4,5-dihydro-1,3- oxazol-2-amine (synonym: S23515), 6-methylamino-2methylheptene (synonym: isometheptene), and 4-chloro-2,3-dihydro-2-oxo-1,3-benzothiazol-3-ylacetic acid (synonym: benazolin). Also, to the use of Imidazole propionate in the diagnosis of an autoinflammatory or autoimmune disease in a subject, and further to a method of diagnosis of atherosclerosis comprising assessing the level of ImP in a blood sample and determining whether said level is above or below a value of 41nM.

The invention relates to a double-tailed hydrophobic associated polymer oil-displacing agent with a benzene ring structure and a preparation method thereof. The oil-displacing agent is formed by copolymerizing three monomers, namely acrylamide, 2-allyl methylamino sodium ethanesulfonate and a hydrophobic monomer double-tailed long-chain alkyl methyl (p-3-carboxyl acrylamide benzyl) ammonium chloride with the benzene ring structure. The preparation method comprises the following steps: firstly adding distilled water, then adding acrylamide, 2-allyl methylamino sodium ethanesulfonate and a hydrophobic monomer double-tailed long-chain alkyl methyl (p-3-carboxyl acrylamide benzyl) ammonium chloride with a benzene ring structure, supplementing water, adjusting the total concentration, introducing N2 to remove oxygen, adding an initiator, and reacting at a certain temperature to prepare the terpolymer. The prepared polymer oil-displacing agent has good water solubility, temperature resistance and shearing resistance, shows good salt resistance in saline water with the mineralization degree larger than or equal to 30000 mg / L and shows a good oil-displacing effect in a heterogeneous core oil-displacing experiment, and the crude oil recovery rate can be increased by 10% or above.

The invention belongs to the field of medicinal chemistry, and particularly discloses a benzimidazole amine derivative, a preparation method thereof and application of the benzimidazole amine derivative as a beta2-adrenergic receptor allosteric antagonist. According to the benzimidazole amine derivative disclosed by the invention, R1 is a hydrogen atom or a bromine atom; r2 is substituted benzoyl, substituted benzyl and the like. Pharmacological results show that the benzimidazole amine derivative disclosed by the invention has relatively good antagonistic activity on beta2AR, and the functional activity of isoprenaline (ISO) can be subjected to negative allosteric regulation.

The invention provides a composition with an instant and long-acting anti-aging effect and application thereof. The composition comprises a component A, a component B and a component C, the mass ratio of the raw materials is (1-10): (1-4): (0.05-0.2); the component A is prepared from the following components in parts by weight: 0.01 to 0.5 part of acetyl octapeptide-3, 0.01 to 0.5 part of dipeptide diaminobutyryl benzyl amide diacetate, 0.001 to 0.2 part of arginine / lysine polypeptide, 0.3 to 1 part of caprylyl glycol and 96 to 100 parts of water; the component B is prepared from the following components in parts by weight: 0.001 to 0.2 part of soluble collagen, 5 to 30 parts of glycerol, 0.01 to 0.5 part of sodium dihydrogen phosphate, 0.001 to 0.2 part of disodium hydrogen phosphate and 65 to 100 parts of water; and the component C is tripeptide-29. According to the invention, the quadruple wrinkle fading polypeptide is adopted to block wrinkles in a multi-target full-link manner, so that the product has a very good effect of fading various wrinkles in real time.

The present invention relates to a multi-aziridine compound having: a) at least 2 of the following structural units (A): (A) whereby R1 is H; R2 and R4 are independently chosen from H, a linear group containing from 1 to 8 carbon atoms and optionally containing one or more heteroatoms, a branched or cyclic group containing from 3 to 8 carbon atoms and optionally containing one or more heteroatoms, phenyl, benzyl, or pyridinyl; R3 is chosen from a linear group containing from 1 to 8 carbon atoms and optionally containing one or more heteroatoms, a branched or cyclic group containing from 3 to 8 carbon atoms and optionally containing one or more heteroatoms, phenyl, benzyl, or pyridinyl; or R2 and R3 (in case R2 is different than H) may be part of the same cyclic group containing from 3 to 8 carbon atoms; R′ and R″ are independently H or an aliphatic hydrocarbon group containing from 1 to 12 carbon atoms; and b) a molecular weight from 600 to 20000 Daltons, wherein the molecular weight is determined using MALDI-TOF mass spectrometry according to the description.

The invention relates to a bisulfonate hydrophobic association polymer oil-displacing agent with a benzene ring structure and a preparation method thereof. The polymer oil-displacing agent is formed by copolymerization of three monomers, namely acrylamide, sodium 2-allyl methylamino ethanesulfonate and long-chain alkyl disulfoethyl (4-vinyl benzyl) betaine which is a hydrophobic monomer with the benzene ring structure. The preparation method comprises the following steps: firstly adding distilled water, sequentially adding acrylamide, 2-allylmethylamino sodium ethanesulfonate and long-chain alkyl disulfoethyl (4-vinyl benzyl) betaine, adding water to adjust the total concentration, introducing N2 to remove oxygen, adding an initiator, and reacting at a certain temperature to obtain the terpolymer. The polymer oil-displacing agent prepared by the invention has good water solubility and good temperature resistance and shear resistance, shows good salt resistance in saline water with the degree of mineralization being greater than or equal to 30000 mg / L, shows a good oil-displacing effect in heterogeneous rock cores, and can improve the crude oil recovery rate by 10% or above.

The invention discloses a polyether-ether-ketone polishing brush wire material and a preparation method thereof, and belongs to the technical field of brush wire material preparation. The polyether-ether-ketone polishing brush wire material is prepared from, by weight, 50-70 parts of polyether-ether-ketone, 8-13 parts of a modified flexibilizer, 5-10 parts of a modified stabilizer, 3-6 parts of a light stabilizer, 6-12 parts of a lubricant and 2-5 parts of graphite, the modified flexibilizer is prepared from allyl glycidyl ether, benzyl dimethyl silane, vinyl acetic acid and 4-methoxyphenol, and the modified flexibilizer is prepared from vinyl acetate and 4-methoxyphenol. The modified stabilizer is prepared from pentafluorobenzoic acid, potassium tert-butoxide, 1, 10-phenanthroline, pentafluorobromobenzene, 4-aminophenol and pyromellitic dianhydride. The polyether-ether-ketone polishing brush wire material prepared by the method has excellent toughness, organic solvent resistance and wear resistance.

The invention provides a polybenzyl chloride type monomolecular resin photoresist based on an adamantane structure as well as a preparation method and application of the polybenzyl chloride type monomolecular resin photoresist. According to the invention, the advantages of non-chemically amplified photoresist and monomolecular resin are combined, and a series of monomolecular resin based on adamantane core and periphery grafted benzyl chloride groups are synthesized. The series of compounds are simple in synthesis process, have very high thermal stability and good film-forming property, and can meet the requirements of a photoresist process. Electron beam and extreme ultraviolet lithography show that the series of photoresist materials are expected to meet the requirement of high-resolution lithography.

The invention belongs to the technical field of chemical synthesis of medicines, and particularly relates to a preparation method of a CETP inhibitor Obicterapib. The invention provides three preparation schemes. According to the scheme I, 2-phenyl pentenoate and (R)-N-(1-phenethyl)-4-(trifluoromethyl) aniline are subjected to a reaction, and a target compound Obicterapib is prepared through hydrolysis, cyclization, acylation, asymmetric chiral amine and other multi-step reactions; according to the second scheme, 4-halogenated benzotrifluoride reacts with (R)-3-amino valeronitrile, then nitrile hydrolysis is carried out, the product reacts with ethyl chloroformate, bis (trifluoromethyl) benzyl bromide, bis (pinacolato) diboron and ethyl 4-bromobutyrate, and finally hydrolysis is carried out to prepare the target compound Obictapib. According to the third scheme, (R)-3-(4-trifluoromethyl-phenyl amino)-valeric acid is substituted by amino to obtain a compound (R)-3-[4-(trifluoromethyl) phenyl amino]-valeric acid amide, then the compound (R)-3-[4-(trifluoromethyl) phenyl amino]-valeric acid amide reacts with ethyl chloroformate, bis (trifluoromethyl) benzyl bromide, bis (pinacolato) diboron, ethyl 4-bromobutyrate and 5-bromine-2-chloropyrimidine, and finally hydrolysis is conducted to prepare the target compound Obictapib.

The application belongs to the technical field of oil and gas field development, and provides a phase permeability improver, a fracturing fluid system containing the same, and respective preparation methods and applications. The phase permeability improver is obtained by copolymerization and hydrolysis of acrylamide AM, a functional monomer 2-acrylamido-2-methylpropanesulfonic acid AMPS, and cationic hydrophobic monomers A and B; the cationic hydrophobic monomer A is at least one of tetradecyl dimethyl allyl ammonium chloride, hexadecyl dimethyl allyl ammonium chloride, and octadecyl dimethyl allyl ammonium chloride; the cationic hydrophobic monomer B is at least one of methacryloyloxyethyl trimethyl ammonium chloride, acryloyloxyethyl trimethyl ammonium chloride, and acryloyloxyethyldimethyl benzyl ammonium chloride; the phase permeability improver and the fracturing fluid system containing the same can significantly reduce the water phase permeability after fracturing operation, while having a smaller influence on the oil phase permeability, and have a significant effect of stabilizing oil and controlling water, and can significantly improve the stable production effect of fracturing operation in a low-permeability oil reservoir.

Disclosed is a pharmaceutical composition for the treatment of tumors, the pharmaceutical composition comprising (6S, 9aS)-N-benzyl-8-({6-[3-(4-ethylpiperazin-1-yl) azetidin-1-yl] pyridin-2-yl} methyl)-6-(2-fluoro-4-hydroxybenzyl)-4, 7-dioxo-2-(propyl-2-en-1-yl) hexahydro-2H-pyrazino [2, 1-c] [1, 2, 3] triazolo [1, 2, 4] triazolo [1, 2, 4] triazolo [1, 2, 4] triazolo [1, 2, 4] triazolo [1, 2, 4] triazolo [1, 2, 4] triazolo [1, 2, 4] triazolo [1, 2, 4] triazolo [ The present invention relates to a compound of formula (I) or a pharmaceutically acceptable salt thereof and administered in combination with a MEK inhibitor.

The invention discloses a synthesis method of an aryl bidentate phosphine compound, which comprises the following steps of: (1) reacting benzene or alkylbenzene with benzyl chloride or 4-alkyl benzyl chloride at 0-100 DEG C for 0.5-5 hours in the absence of oxygen and under the condition of a lewis acid catalyst to prepare a first intermediate; (2) dropwise adding an alkyl lithium reagent into tetramethylethylenediamine at the temperature of-30 to 40 DEG C under the conditions of no water, no oxygen and a solvent, stirring for 1 to 3 hours, dropwise adding the first intermediate into the mixed solution at normal temperature, and reacting for 4 to 20 hours at the temperature of-20 to 40 DEG C to prepare a second intermediate; and (3) under anhydrous and anaerobic conditions, adding diphenyl phosphine chloride into the second intermediate obtained in the step (2), and reacting at-20 to 80 DEG C for 5-60 hours to obtain the aryl bidentate phosphine compound. The synthesis method disclosed by the invention is simple in process, mild in condition and high in product yield, and has a relatively good industrial prospect.

The invention discloses a preparation method of battery-grade lithium trifluoromethanesulfinate, which comprises the following steps: reacting sodium trifluoromethanesulfinate with benzyl halide in a solvent to prepare benzyl trifluoromethyl sulfone, and carrying out hydrogenation reduction on the benzyl trifluoromethyl sulfone under the catalysis of a catalyst to prepare trifluoromethanesulfinic acid, according to the method, all the adopted raw materials are industrial chemicals and are low in price and easy to obtain, the reaction process is mild and controllable, the product purity is high, the battery use requirement is met, and the method has the industrialization prospect.

The invention relates to a method for preparing a nerofloxacin chiral piperidylamine intermediate, which comprises the following steps of: carrying out condensation reaction on 5-hydroxy nicotinic acid which is simple and easy to obtain and is used as a raw material and different alcohols, screening through a series of asymmetric catalytic hydrogenation conditions to obtain optimal reaction conditions, and under the conditions, carrying out reaction on various 3, 3 '-dihydroxy nicotinic acid and 3, 3'-dihydroxy nicotinic acid to obtain the nerofloxacin chiral piperidylamine intermediate. The 2, 5-disubstituted pyridine quaternary ammonium salt is reduced into a tetrahydropyridine product, and the C5 site enantioselectivity of the product is excellent. The preparation method comprises the following steps: selecting methyl (R)-1-benzyl-5-hydroxy-1, 4, 5, 6-tetrahydropyridine-3-carboxylic acid methyl ester as a substrate, completely hydrogenating by using platinum dioxide hydrogen, and then carrying out methyl ester reduction, dehydroxylation, Mitsunobu reaction and protecting group removal to obtain a key chiral intermediate for industrial synthesis of a quinolone antibacterial drug nemonofloxacin with high enantioselectivity and high yield.

The preparation and properties of crystalline polymorphs and solvates of 1-benzyl-8-methyl-1,4,8-triazaspiro-[4.5]-decan-2-one free base and of the mono- and dihydrochloride salts and solvates thereof are disclosed, as is an amorphous polymorph of the dihydrochloride. A pharmaceutical composition containing one or more polymorphs and a method of using that composition are also disclosed.

The invention provides a preparation method of an efficient selective antagonist BQ-788, and relates to the technical field of preparation of antagonists. A solid-liquid combination method is adopted for synthesis, due to the fact that dimethyl dialkanoate on a side chain of tryptophan (DTrp) is difficult, Fmoc-DTrp (CO2Me)-OH is obtained through liquid-phase synthesis, p-methoxybenzyl is selected for protecting carboxyl in the synthesis process, the carboxyl can be removed through trifluoroacetic acid subsequently, and the risk that an indole ring of tryptophan is reduced due to hydrogenation can be successfully avoided. According to the present invention, by using the solid phase synthesis method, the fragment can be rapidly and efficiently obtained, the racemization problem during the condensation process can be effectively avoided, the urea is formed on the solid phase, the operation is simple and convenient, the hydrogen and the diphosgene are not used during the preparation process, the production is safe, the obtained product has characteristics of high yield and high purity, and the preparation steps are less.

The invention discloses a high-temperature-resistant nylon composite material and a production process thereof, and belongs to the technical field of nylon composite material preparation. The high-temperature-resistant nylon composite material is prepared from the following components in parts by weight: 35-48 parts of nylon resin, 7-12 parts of a heat-resistant agent, 3-8 parts of a modified anticorrosive agent, 1-3 parts of calcium stearate, 1-3 parts of a flame retardant and 2-10 parts of glass fibers, and the heat-resistant agent is prepared from 2, 4-dinitrophenol, hydrazine hydrate, p-nitrobenzoic acid, triethylamine, polyphosphoric acid and 2, 4-dinitrophenol. The nylon composite material is prepared from 2, 2 '-bis (3, 4-dicarboxylic acid) hexafluoropropane dianhydride, and the modified anticorrosive agent is prepared from fluororubber, benzyltriethylammonium chloride, lithium aluminum hydride and isophorone diisocyanate. The nylon composite material prepared by the method has excellent high temperature resistance and corrosion resistance.